Based on your age, you and your doctor can use the following ranges to interpret your results for early-stage invasive cancer. You and your doctor will consider the Recurrence Score in combination with other factors, such as the size and grade of the cancer and the number of hormone receptors the cancer cells have many vs. Together, you can make a decision about whether or not you should have chemotherapy.
DCIS is the most common form of non-invasive breast cancer. DCIS usually is treated by surgically removing the cancer lumpectomy in most cases. After surgery, hormonal therapy may be recommended if the DCIS is hormone-receptor-positive most are. Radiation therapy may be recommended for some women. You and your doctor can use the following ranges to interpret your results for DCIS:.
You and your doctor will consider the Recurrence Score in combination with other factors, such as the size and grade of the DCIS and the number of hormone receptors the cancer cells have many vs. Together, you can make a decision about whether or not you should have radiation therapy. Learn about Susan G. These two Oncotype DX tests are similar, but not exactly the same.
Skip to content. Tumor profiling Every cell in your body has genes that contain the blueprints genetic code for your body. Oncotype DX testing Oncotype DX tests a sample of the tumor removed during a biopsy or surgery for a group of 21 genes.
Benefit of chemotherapy for some ER-positive breast cancers The results of the Oncotype DX test help predict the chance of metastasis when cancer spreads to other organs and the likelihood of benefit of getting chemotherapy in addition to hormone therapy. Breast cancer staging Oncotype DX can be included as part of breast cancer staging for some estrogen receptor-positive, lymph node-negative tumors [ 33 ]. When can Oncotype DX be used?
Oncotype DX helps predict the chance of metastasis and the likelihood of benefit from chemotherapy for early breast cancers that are all of the following [ 16, ]: Tumor size smaller than 5 cm ER-positive and will be treated with hormone therapy HER2-negative Lymph node-negative or positive lymph nodes If Oncotype DX testing is right for you, your oncologist will review your test results with you and discuss how the Oncotype DX score may guide your treatment plan.
The decision about radiotherapy will depend on the type of surgery you had. Your doctor will discuss your individual treatments with you in detail. Web Design and Development by Annertech. It can: Give more information about the likelihood of your cancer coming back in the future Help your doctors decide if you will benefit from chemotherapy as part of your treatment Who is the Oncotype DX test useful for?
This means that the breast cancer is stimulated by the hormone oestrogen Lymph node negative cancer. This means there that there are no cancer cells in your lymph glands Lymph node positive cancer with cancer cells in lymph nodes HER2 negative cancer.
This means that the cancer does not have high levels of the HER2 protein How is the test done? Your specialist may recommend the Oncotype DX test if the benefit of chemotherapy for you is less clear.
Chemotherapy may be given after surgery to reduce the risk of breast cancer coming back in future. These include:. The test is done on a small amount of breast cancer tissue already removed for example during a core biopsy or surgery. The tissue is sent to a laboratory in the USA, where the test is carried out. The test looks at groups of genes found in breast cancer. The results are given separately from your pathology report and are sent to your specialist within 10 to 14 days.
0コメント